Tag Archives: Dr Jo Cambridge

Norwegian Rituximab trial update

The Norwegian multicenter Rituximab study begins The long-awaited Norwegian phase III study of Rituximab as a treatment for ME/CFS is now getting off the ground. The study is led by the oncologists Prof Olav Mella and Dr Øystein Fluge at … Continue reading

Posted in News | Tagged , , , , , | Comments Off on Norwegian Rituximab trial update